A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies

Status Completed

Clinical Trial Summary

The purpose of this study is to test the safety of a new drug, IPH2201, to see what effects it has on this type of cancer.

Clinical Trial Description

This research is being done because there is no treatment that will cure this type of cancer. Although some types of chemotherapy may cause this cancer to shrink for a time, better options are needed. In laboratory tests and animals, IPH2201 has been shown to have effects which result in shrinkage of tumours. IPH2201 has been studied in people with rheumatoid arthritis but it has not yet been studied in people with cancer and the investigators do not know if it can offer better results than standard treatment. The standard or usual treatment for this disease could include surgery, chemotherapy or radiation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02459301
Study type	Interventional
Source	Canadian Cancer Trials Group
Contact
Status	Completed
Phase	Phase 1
Start date	September 17, 2015
Completion date	November 12, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04890327` - Web-based Family History Tool	N/A
Not yet recruiting	`NCT05467319` - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS	Phase 3
Recruiting	`NCT05478876` - Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract	N/A
Active, not recruiting	`NCT04899492` - Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery	N/A
Terminated	`NCT03658109` - Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone	Early Phase 1
Recruiting	`NCT05296512` - Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer	Phase 2
Suspended	`NCT03158636` - Profiling of Oncology Patients as Part of Clinical Care and Research
Completed	`NCT01679483` - Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer	N/A
Completed	`NCT01444924` - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery	Phase 2
Recruiting	`NCT05053230` - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer	N/A
Recruiting	`NCT04534075` - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial	Phase 3
Active, not recruiting	`NCT04584957` - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)	N/A
Completed	`NCT03292328` - Yoga for Symptoms of Nerve Damage Caused by Chemotherapy	N/A
Completed	`NCT05131490` - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients	N/A
Active, not recruiting	`NCT03899376` - A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT	N/A
Not yet recruiting	`NCT05407987` - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)	Phase 3
Recruiting	`NCT05891470` - To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT	N/A
Not yet recruiting	`NCT05974995` - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer	N/A
Withdrawn	`NCT04368130` - SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care	N/A
Recruiting	`NCT04806724` - Opening the Conversation Study	N/A